Previous 10 | Next 10 |
MALVERN, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’...
MALVERN, Pa., Oct. 27, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’...
MALVERN, Pa., Oct. 26, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own ana...
Summary Shares of TELA Bio have fallen by 40% since public offering in 2019. Differentiation for OviTex versus competitors in terms of clinical outcomes and economics could help them transition from niche player to broad provider. GPO wins, especially Premier, should cause sal...
Medical technology company TELA Bio ( NASDAQ: TELA ) has closed an underwritten public offering of 4.6M shares at $8.00 per share for gross proceeds of $36.8M. The offering includes 600K shares sold pursuant to the full exercise of the underwriter's option to purchase...
MALVERN, Pa., Aug. 18, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’...
Save Foods ( SVFD ) -35% on pricing of $4.8M stock offering . Albireo Pharma ( ALBO ) -23% on Q2 earnings release . Tremor International ( TRMR ) -17% on Q2 earnings release . GAN ( GAN ) -17% on Q2 earnings release . Hel...
Tela Bio ( NASDAQ: TELA ) priced an offering of 4M common shares at $8 apiece to raise $32M in gross proceeds. The company granted the underwriter a 30-day option to buy up to an additional 600K shares. Tela intends to use the net proceeds for working capital a...
TELA Bio ( NASDAQ: TELA ) on Monday announced an underwritten public offering of shares . TELA expects to grant the underwriter a 30-day option to buy up to an additional 15% of the shares to be sold in the proposed offering at the public offering price. There can be n...
Image source: The Motley Fool. TELA Bio, Inc. (NASDAQ: TELA) Q2 2022 Earnings Call Aug 10, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: TELA Bio, Inc. (TELA) Q2 2022 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
MALVERN, Pa., July 25, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the Canaccord Genuity 44 th Annual Growth Con...
MALVERN, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report second quarter 2024 financial results on Mon...
2024-06-27 06:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...